The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples